The Algocyte ecosystem
Precision healthcare. Predictive medicine.
Algocyte is a diagnostics platform company incubated by the University of Oxford and spun out of King's College London, with research and studies across the Cambridge and NHS ecosystems. By combining advanced physics with causal AI, Algocyte can build a personalised digital twin that learns each person's baseline tracking meaningful change over time.
Vision
Algocyte's vision is to transform healthcare starting by providing a more complete picture of cancer patients undergoing treatment by connecting physical diagnostics with the evolving context of each individual. From a measurement near the patient to a clinician's longitudinal view, the Algocyte ecosystem brings together the information needed for a more personalised, anticipatory care collecting and combining symptoms, lifestyle and medical data.
Diagnostic measurements move closer to patients across suitable care settings.
Individual physiological baselines supplement population reference intervals.
Meaningful changes can be reviewed over time, potentially before conventional thresholds are crossed.
Occasional healthcare interactions become an ongoing, data-informed relationship between patients and healthcare providers.
The Algocyte ecosystem
Complementary tools that work seamlessly together as a cohesive unit to offer an end-to-end solution to health monitoring and a meaningful single point of care.
Physical diagnostics at home
A Physical-AI portable device designed for at-home use, guided and supervised by a healthcare professional.
Operated by a mobile app, it runs the most popular medical test, a full blood count (FBC), a key measure of immune system health, from a small blood sample taken by finger prick or shoulder patch in about 15 minutes, with results shared soon after with a healthcare professional.
Explore Algocyte Proxima
Context for every measurement.
Medical records, laboratory results, patient-reported information, lifestyle, wearables and compatible home measurements form a longitudinal clinical view all in the same place.
Learning personal reference intervals, trends and clinician-led questions support a continuing care relationship for precision healthcare and predictive medicine led by sophisticated computational-intelligence tools.
Explore HealthHub
Essential to the measurement workflow.
The consumables, collection materials and test components that support the Algocyte Proxima workflow.
Single-use cartridges with long shelf life and no cold chain required.
Explore Consumables
From device connectivity to clinical operations.
The Algocyte Connect App guides each test step and controls Algocyte Proxima over the phone's Bluetooth. Algocyte TestHub lets healthcare professionals assign devices, review results and release them across the Algocyte Proxima fleet.
See the ecosystemBayesian differential diagnosis with traceability.
Florence 1.0 and Ada 1.0 are AlgocyteGPt's specialised agentic large language models. Founded on Bayesian inference, they help create ultra-personalised questionnaires from all the multimodal data sources collected across the Algocyte ecosystem, to support differential diagnosis and build a clinical digital twin over time.
Explore AlgocyteGPt™For clinicians
Healthcare teams have full bi-directional control from the Algocyte TestHub™ dashboard over their Algocyte Proxima fleet across patients deployed at hospitals and clinics. They can review results, consult records and release reports back to patients. EMR/EHR integration through LIMS capability keeps existing workflows intact while monitoring moves beyond the point of care and into the home.
Algocyte TestHub supports assigning, reviewing and releasing results across the Algocyte Proxima fleet.
Objective measurements and longitudinal trends complement patient-reported symptoms, giving remote consultations a richer evidence base. Care teams can follow changes, ask targeted questions and review the patient's evolving record between visits.
Now, vs. next.
From clinical visits and needles in a fragmented but centralised system, to a minimally-invasive multimodal merging and collecting device centralised in the living room.
Today
Appointments, waiting rooms, needles, lab turnaround. A snapshot, weeks late.
Future with Algocyte
Regular readings at home, an expanding test menu, and data flowing into one AI-driven HealthHub.
SCIENCE
Unique dual-sensor haematological analyser that keeps in check the AI and anchors its quantum mechanics-inspired AI in physics and biology to produce the patient's blood test results. An AI based on physics, not words or tokens.
Learn the technology
VISION
Patient and clinician both control the data flow. Results reach the clinician's dashboard in minutes, and the clinician decides whether to share them online or offline with interpretation guidance.
Read the technology
How it works
Single-use CE-marked cartridges and no cold chain required ready for plug-and-play operation.
Small sample, or a gentle patch. Algocyte handles the rest, reporting results to the healthcare professional.
Sensors capture the physical signal; AI converts signals to biological and clinically meaningful values.
Results land on the clinician's dashboard that can release the results to their patients together with any explanation or interpretation.
Personal health intelligence, in one place the individual controls.
Learn moreOncology pathways and dashboards with EHR integration capability.
Learn moreOutcome data for value-based contracts and lower spend.
Learn moreSponsor-supported oncology and decentralized trials.
Learn moreAlgocyte HealthHub™
The personal and family Algocyte HealthHub manages patient and family health information over time. It brings together three complementary layers of data.
Objective medical data
Blood-test results, laboratory and uploaded medical reports, and the Algocyte index related to immune biological age and triage, in one longitudinal view, with each marker compared against the person's own range as well as population ranges.
Contextual data
With consent, wearable-derived and lifestyle information such as activity, heart rate, sleep, glucose and insulin readings sits alongside every test, so trends can be read against how the person actually lives.
Subjective data
Ultra-personalised questionnaires generated by AlgocyteGPt™, a specialised large language model for interpreting blood-test results and other uploaded medical records. Clinicians can delete, augment or tweak each question.
By learning each person's baseline↗ and analysing trends against aggregated blood-test results, the Algocyte HealthHub™ helps clinicians spot drift earlier and supports structured clinical context for early detection, precision healthcare and predictive medicine.
Evidence
Algocyte brings together physical measurement, research on individual physiological set points, computational biomarkers and clinical interpretation. Evidence is presented for each part of the ecosystem alongside its intended use and regulatory status.
Nearly 20 years of research across blood, cell and molecular biology, spanning Karolinska, Oxford, Cambridge and King's College London, inform Algocyte's neurosymbolic and causal AI foundations.
Algocyte platform Version R1 is CE-marked. Algocyte Proxima is UKCA-marked as a General IVD within its stated intended use. Company ISO 13485 and ISO 27001 certifications cover the relevant management systems. Product, version, feature and market scope matters.
Regulatory information and certificatesAbout
75 Years of NHS Official Partner
Future Blood Testing Network+
Incubated at Oxford, spun out from King's College London, with clinical leadership and research rooted in the NHS and Cambridge ecosystems.
See Algocyte in action.
